Literature DB >> 26280083

MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.

Shan Lu1,2,3, Wei Zhou4, Haiyun Wei4, Leifeng He5, Liang Li5.   

Abstract

BACKGROUND: Emerging evidence suggests that MTBP plays a role in cancer development and possibly progression, but its influence on hepatocellular carcinoma (HCC) remains unclear.
METHODS: We used real-time PCR and Western blotting to investigate MTBP expression in four HCC cell lines, 120 pairs of tumor and corresponding paracarcinomatous tissues from HCC patients. Immunohistochemistry was performed to examine MTBP expression in HCC and corresponding paracarcinomatous tissues from 120 patients. E-cadherin was only examined in HCC tissues of patients mentioned above. Statistical analyses were applied to evaluate the prognostic value and associations of MTBP expression with clinical parameters. Furthermore, the MTBP gene was overexpressed in HepG2 cell and silenced by siRNA in Hu7 cell, and cell migration and invasion were detected in vitro and in vivo. Moreover, the molecular mechanism of E-cadherin regulation by MTBP was explored.
RESULTS: In this study, we first showed that MTBP protein expression is positively correlated with distant metastasis and poor prognosis in HCC patients. We also found that MTBP expression was increased in metastatic cell lines when compared with nonmetastatic cell lines. Consistent with these findings, enhanced expression of MTBP promoted HCC cell invasiveness and metastasis both in vitro and in vivo, whereas the knockdown of MTBP with small interfering RNA resulted in reduced HCC migration and invasion. Ectopic expression of MTBP in HCC cells induced epithelial-to-mesenchymal transition, whereas the silencing of MTBP had the opposite effect. Furthermore, our results show that MTBP and E-cadherin protein expression are inversely correlated in primary HCC tissues. Moreover, our findings indicate that MTBP overexpression decreases E-cadherin expression through the modulation of Mdm2 ubiquitination degradation.
CONCLUSIONS: Our data show that MTBP aggravates the invasion and metastasis of HCC by promoting the MDM2-mediated degradation of E-cadherin.

Entities:  

Keywords:  E-cadherin; Hepatocellular carcinoma; Invasion; MTBP; Ubiquitination

Mesh:

Substances:

Year:  2015        PMID: 26280083     DOI: 10.1007/s10620-015-3824-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

2.  A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2.

Authors:  M T Boyd; N Vlatkovic; D S Haines
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

3.  Oncogenic protein MTBP interacts with MYC to promote tumorigenesis.

Authors:  Brian C Grieb; Mark W Gramling; Maria Pia Arrate; Xi Chen; Stephen L Beauparlant; Dale S Haines; Hua Xiao; Christine M Eischen
Journal:  Cancer Res       Date:  2014-05-01       Impact factor: 12.701

4.  MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.

Authors:  Jiabei Wang; Tongsen Zheng; Xi Chen; Xuan Song; Xianzhi Meng; Nishant Bhatta; Shangha Pan; Hongchi Jiang; Lianxin Liu
Journal:  J Gastroenterol Hepatol       Date:  2011-02       Impact factor: 4.029

Review 5.  Clinical, cellular, and molecular aspects of cancer invasion.

Authors:  Marc Mareel; Ancy Leroy
Journal:  Physiol Rev       Date:  2003-04       Impact factor: 37.312

6.  High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.

Authors:  R M Bremnes; R Veve; E Gabrielson; F R Hirsch; A Baron; L Bemis; R M Gemmill; H A Drabkin; W A Franklin
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

7.  A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.

Authors:  J Odvody; T Vincent; M P Arrate; B Grieb; S Wang; J Garriga; G Lozano; T Iwakuma; D S Haines; C M Eischen
Journal:  Oncogene       Date:  2010-03-22       Impact factor: 9.867

8.  Identification of a heteromeric complex that promotes DNA replication origin firing in human cells.

Authors:  Dominik Boos; Mona Yekezare; John F X Diffley
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

9.  MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.

Authors:  C Zietz; M Rössle; C Haas; A Sendelhofert; A Hirschmann; M Stürzl; U Löhrs
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 10.  Alternative and aberrant splicing of MDM2 mRNA in human cancer.

Authors:  Frank Bartel; Helge Taubert; Linda C Harris
Journal:  Cancer Cell       Date:  2002-07       Impact factor: 31.743

View more
  7 in total

1.  [MTBP regulates migration and invasion of prostate cancer cells in vitro].

Authors:  Zhuoyu Xiao; Mingkun Chen; Jiankun Yang; Cheng Yang; Xianyuan Lü; Hu Tian; Cundong Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-01-30

Review 2.  MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging.

Authors:  Brian C Grieb; Christine M Eischen
Journal:  Biology (Basel)       Date:  2022-06-08

3.  Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis.

Authors:  Atul Ranjan; Kaustav Bera; Tomoo Iwakuma
Journal:  Hepatoma Res       Date:  2016-05-06

4.  MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.

Authors:  Yifu Song; Li Zhang; Yang Jiang; Tianhao Hu; Di Zhang; Qiao Qiao; Run Wang; Minghao Wang; Sheng Han
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

5.  MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells.

Authors:  Hongbo Wang; Fang Chu; Li Zhijie; Qian Bi; Li Lixin; Yunlong Zhuang; Zhang Xiaofeng; Xiaofeng Niu; Dali Zhang; He Xi; Bo-An Li
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

6.  MTBP promotes migration and invasion by regulation of ZEB2-mediated epithelial-mesenchymal transition in lung cancer cells.

Authors:  Bo Pan; Haibo Han; Lina Wu; Ying Xiong; Jianzhi Zhang; Bin Dong; Yue Yang; Jinfeng Chen
Journal:  Onco Targets Ther       Date:  2018-10-10       Impact factor: 4.147

7.  MDM2 Binding Protein Induces the Resistance of Hepatocellular Carcinoma Cells to Molecular Targeting Agents via Enhancing the Transcription Factor Activity of the Pregnane X Receptor.

Authors:  Qiyu Jiang; Yan Ma; Jingjing Han; Jingdong Chu; Xuemei Ma; Lijun Shen; Bo Liu; Bo-An Li; Jun Hou; Qian Bi
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.